We are live on ! Find out more
PMVP icon

PMV Pharmaceuticals
PMVP

85 hedge funds and large institutions have $1.44B invested in PMV Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 15

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

10% more capital invested

Capital invested by funds: $1.31B → $1.44B (+$130M)

5% more funds holding

Funds holding: 81 → 85 (+4)

4.68% more ownership

Funds ownership: 89.14% → 93.82% (+4.7%)

Holders
85
Holders Change
+4
Holders Change %
+4.94%
% of All Funds
1.48%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
16
Increased
42
Reduced
15
Closed
12
Calls
$1.44M
Puts
–
Net Calls
+$1.44M
Net Calls Change
+$1.44M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$35.2M
2
JP Morgan Chase
JP Morgan Chase
New York
+$23.6M
3
BlackRock
BlackRock
New York
+$16.4M
4
DM
Deerfield Management
New York
+$12.7M
5
State Street
State Street
Massachusetts
+$12.5M

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$17.9M
2
IVM
InterWest Venture Management
California
-$16.7M
3
PCS
Personal CFO Solutions
New Jersey
-$15.7M
4
Viking Global Investors
Viking Global Investors
Connecticut
-$9.89M
5
EC
Euclidean Capital
New York
-$9.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
Prudential Financial
51
Prudential Financial
New Jersey
$1.16M +$56.9K +1,703 +5%
State of Wisconsin Investment Board
52
State of Wisconsin Investment Board
Wisconsin
$1.16M +$518K +15,500 +84%
Ameriprise
53
Ameriprise
Minnesota
$1.14M +$597K +17,887 +103%
Swiss National Bank
54
Swiss National Bank
Switzerland
$844K +$825K +24,700 New
Blackstone Inc
55
Blackstone Inc
New York
$816K +$798K +23,888 New
HS
56
HighVista Strategies
Massachusetts
$812K +$96.2K +2,880 +14%
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
$805K +$319K +9,536 +68%
PPA
58
Parametric Portfolio Associates
Washington
$774K +$56.6K +1,694 +8%
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
$773K +$331K +9,917 +78%
AllianceBernstein
60
AllianceBernstein
Tennessee
$663K +$321K +9,600 +98%
TD Asset Management
61
TD Asset Management
Ontario, Canada
$639K +$628K +18,800 New
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$501K +$236K +7,065 +93%
Susquehanna International Group
63
Susquehanna International Group
Pennsylvania
$414K +$404K +12,109 New
CSS
64
Cubist Systematic Strategies
Connecticut
$396K +$387K +11,599 New
Voloridge Investment Management
65
Voloridge Investment Management
Florida
$365K +$357K +10,678 New
MIM
66
MetLife Investment Management
New Jersey
$362K -$368K -11,013 -51%
VOYA Investment Management
67
VOYA Investment Management
Georgia
$351K +$133K +3,983 +63%
CS
68
Credit Suisse
Switzerland
$307K +$301K +9,004 New
Envestnet Asset Management
69
Envestnet Asset Management
Illinois
$269K +$263K +7,872 New
HP
70
Harbourvest Partners
Massachusetts
$263K – – –
HTC
71
Hershey Trust Company
Pennsylvania
$263K – – –
ProShare Advisors
72
ProShare Advisors
Maryland
$232K +$227K +6,804 New
VEA
73
Virtus ETF Advisers
New York
$224K +$219K +6,556 New
SO
74
STRS Ohio
Ohio
$208K +$93.5K +2,800 +85%
Handelsbanken Fonder
75
Handelsbanken Fonder
Sweden
$205K +$200K +6,000 New
1 2
3
4

PMVP Hedge Fund Activity: Q2 2021 in Review

85 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in PMV Pharmaceuticals (PMVP) for Q2 2021, worth a combined $1.44B — up 9.9% from $1.31B a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new PMVP positions and 12 closed out — a net gain of 4 holders — while 42 added to existing stakes and 15 trimmed.

The largest buyer was Vanguard Group, adding an estimated $35.2M. The largest seller was Avoro Capital Advisors, cutting an estimated $17.9M.

  • 85 institutional investors held PMV Pharmaceuticals (PMVP) as of Q2 2021, up from 81 in Q1 2021.
  • Funds reported $1.44B of PMV Pharmaceuticals stock for Q2 2021, up 9.9% quarter-over-quarter.
  • 16 funds opened new PMV Pharmaceuticals positions in Q2 2021 and 12 closed out, a net change of +4 holders.
  • The largest PMV Pharmaceuticals buyer in Q2 2021 was Vanguard Group, an estimated $35.2M added.
  • The largest PMV Pharmaceuticals seller in Q2 2021 was Avoro Capital Advisors, an estimated $17.9M sold.

Based on aggregated 13F filings for Q2 2021.